Respiratory Inhaler Devices Market: Metered Dose Inhaler Most Lucrative Product Type Segment During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

  • Published: 2017-10-25
  • Report Code: REP-GB-5331

An Incisive, In-depth Analysis on the Respiratory Inhaler Devices 102017 Market

This study offers a comprehensive, 360 degree analysis on the Respiratory Inhaler Devices 102017 market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Respiratory Inhaler Devices 102017 market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Introduction

Respiratory inhaler devices are medical devices are used to assist a patient encountering breathing problems resulting from respiratory disorders such as fibrosis, asthma, COPD and ARDS and others. On the basis of product type, the market has been segmented into dry powder inhaler (DPI), metered dose inhaler (MDI) and nebuliser. Nebuliser is further sub-segmented into compressed air nebuliser, ultrasonic nebuliser and mesh nebuliser.

Market Value and Forecast

In terms of value, the global respiratory inhaler devices market is estimated to expand at a CAGR of 4.2% during the forecast period. The global respiratory inhaler devices market value is expected to increase to US$ 44,501.0 Mn by 2027 end.

Market Dynamics

Growth of the global respiratory inhaler devices market is mainly driven by rising prevalence of asthma, chronic respiratory diseases, COPD and other respiratory diseases. However, lack of a single effective inhaler devices for all type of disease indication, side effects and complications during drug inhalation, lack of skilled pulmonologist, physicians and nurses, lack of awareness, coupled with high prices of inhaler devices are factors restraining market growth.

Patients are shifting towards combined therapies due to associated benefits such as more reliable in complex patients, increased efficacy and easy reimbursement policies associated with therapy. Combination therapies cost more compared to conventional therapies for patients with complex indications of respiratory disease. Increase in usage of combination therapies such as triple combination therapy for COPD patients is expected to drive growth of the global respiratory inhaler devices market over the forecast period.

Market Segmentation By Product Type

On the basis of product type, the market has been segmented into dry powder inhaler, metered dose inhaler and nebuliser. In terms of value, the metered dose inhaler segment is estimated to account for over 70.0% share of the global respiratory inhaler devices market by 2017 end, and is expected to remain dominant during the forecast period.

respiratory-inhaler-devices-market.jpg

Market Segmentation By Disease Indication

On the basis of disease indication, the market has been segmented into asthma, COPD, pulmonary arterial hypertension and other respiratory diseases. COPD is expected to be third leading cause of death and fifth leading cause of disability by 2020 end. Numerous health awareness programmes being conducted across the globe are expected to result in the COPD segment registering a CAGR of 4.7% over the forecast period.

Market Segmentation By Technology

On the basis of the technology, market has been segmented into manually operated inhaler devices and digitally operated inhaler devices. Digitally operated inhaler devices is expected to register a CAGR of 3.6% over the forecast period. Application of GPS and Bluetooth technology in inhaler devices is expected to drive demand for digitally operated inhaler devices over the forecast period.

Key Regions

The global respiratory inhaler devices market has been segmented into seven major regions namely North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan (APEJ), Japan, and Middle East & Africa. In terms of value, North America is estimated to dominate the market with 41.3% share of the overall respiratory inhaler devices market by 2017 end. APEJ is estimated to be the significant growing market, registering a CAGR of 4.5% in terms of value over the forecast period. Currently, metered dose inhaler is a major contributor in markets in Europe, North America and parts of Asia Pacific, while nebuliser segment is expected to exhibit a CAGR of 3.6% in terms of value during the forecast period.

Key Players

Some key players identified in the global respiratory inhaler devices market report include: AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare Europe B.V., PARI Medical Holding and Teva Pharmaceutical Industries Ltd. These companies are focusing towards enhancing their product portfolio through the introduction of innovative and cost-effective products to strengthen position in the market in the long term.

Report Description

Future Market Insights offers 10-year forecast on the global respiratory inhaler devices market between 2017 and 2027. This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the global respiratory inhaler devices market over the forecast period. The global respiratory inhaler device market report provides analysis and insights on respiratory inhalers. Primary factors fuelling demand for respiratory inhaler device market are increasing prevalence of asthma, COPD and other respiratory diseases coupled with rising awareness that has triggered the usage of respiratory inhaler devices worldwide. This is expected to bolster the growth of the respiratory inhaler devices market over the next five to six years. Increasing demand for respiratory inhaler devices for controlling asthma and other respiratory disease, especially among children and elderly population, is expected to drive growth of respiratory inhaler devices market during the forecast period. Companies are focusing on regions and sections where prevalence of asthma, and chronic lung diseases are increasing such as Asia Pacific and MEA.

To understand and assess various opportunities in this market, the report is categorically split into four sections, namely market analysis by product type, technology, disease indication and region. The report analyses the global respiratory inhaler device market in terms of value (US$ Mn).

The report starts with an overview of the global respiratory inhaler device. In the same section, FMI covers the global respiratory inhaler device market performance in terms of value. This section also includes FMI’s analysis of key trends, drivers, and restraints from supply and demand perspectives. The report also cover the opportunities in the global respiratory inhaler device market.

The next section of the report analyses the market on the basis of respiratory inhaler device market segment and presents the forecast in terms of value for all years till 2027. The market has been segmented as follows:

By Product Type

  • Dry Powder Inhaler
  • Metered Dose Inhaler
  • Nebulizer
    • Ultrasonic Nebulizer
    • Compressed Air Nebulizer
    • Mesh Nebulizer

By Technology

  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices

By Disease Indication

  • Asthma
  • COPD
  • Pulmonary Arterial Hypertension
  • Others Respiratory Disease

The next section analyses the market on the basis of regions in terms of value for the forecast period. Regions covered in the report are as follows

By Region

  • North America
    • U.S.
    • Canada
  • Latin America
    • Argentina
    • Brazil
    • Mexico
    • Rest of LA
  • Western Europe
    • Germany
    • France
    • U.K
    • Italy
    • Spain
    • Nordic
    • BENELUX
    • Rest of WE
  • Eastern Europe
    • Poland
    • Russia
    • Rest of EE
  • Asia Pacific Excluding Japan
    • China
    • India
    • Australia &b New Zealand
    • ASEAN
    • Rest of APEJ
  • Japan
  • Middle East & Africa
    • GCC countries
    • South Africa
    • North Africa
    • Rest of MEA

To reach market size, the report considers market value of the global respiratory inhaler device across the above-mentioned regions. The market estimation presented in the report evaluates the total revenue generated in the global respiratory inhaler device market over the forecast period. When developing the market forecast, the starting point involves sizing up the current market, which forms the basis of the forecast. For this, FMI conducted interviews with several subject matter experts in the respiratory inhaler device domain across the globe. Given the scenario of the market, FMI triangulated the outcome based on analysis from the supply side, demand side and also the dynamics of the market. In this report, quantification of data has been conducted along with qualitative analysis.

We have also taken into consideration the year-on-year growth of the global respiratory inhaler device market, based on regional growth analysis, to understand the predictability of the market and to identify the key opportunities. Another key feature of this report is the analysis of the global respiratory inhaler device market, by region, which is further segmented on the basis of countries and revenue forecast in terms of absolute dollar (US$) opportunity. Regional trends have been introspected, identified and applied while carrying out the forecasting of the market. Additionally, the absolute dollar opportunity provided in the report is critical in assessing the level of opportunity that a provider can look to achieve from a sales perspective in the global respiratory inhaler device market.

Respiratory Inhaler Devices Market 102017 Reports - Table of Contents

Respiratory Inhaler Devices Market 102017 Reports - List of Tables

Table 01: North America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 02: North America Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 03: North America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 04: North America Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 05: North America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 06: North America Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 07: North America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 08: North America Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 09: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 10: Latin America Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 11: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 12: Latin America Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 13: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 14: Latin America Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 15: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 16: Latin America Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 17: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 18: Western Europe Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 19: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 20: Western Europe Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 21: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 22: Western Europe Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 23: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 24: Western Europe Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 25: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 26: Eastern Europe Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 27: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 28: Eastern Europe Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 29: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 30: Eastern Europe Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 31: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 32: Eastern Europe Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 33: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 34: APEJ Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 35: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 36: APEJ Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 37: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 38: APEJ Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 39: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 40: APEJ Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 41: Japan Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 42: Japan Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 43: Japan Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 44: Japan Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 45: Japan Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 46: Japan Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 47: MEA Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 48: MEA Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 49: MEA Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 50: MEA Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 51: MEA Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 52: MEA Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 53: MEA Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 54: MEA Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 55: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Region, 2012–2017

Table 56: Global Respiratory Inhaler Devices Market Volume (1000`) Forecast by Region, 2012–2017

Table 57: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Product Type, 2012–2017

Table 58: Global Respiratory Inhaler Devices Market Volume (1000`) Forecast by Product Type, 2012–2017

Table 59: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Technology, 2012–2017

Table 60: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Technology, 2012–2017

Table 61: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Disease Indication, 2012–2017

Table 62: Global Respiratory Inhaler Devices Market Volume (1000`) Forecast by Disease Indication, 2012–2017

Respiratory Inhaler Devices Market 102017 Reports - List of Figures

Figure 01: North America Respiratory Inhaler Devices Market Value Share By Product (2017)

Figure 02: North America Respiratory Inhaler Devices Market Value Share By Technology (2017)

Figure 03: North America Respiratory Inhaler Devices Market Value Share By Country (2017)

Figure 04: North America Respiratory Inhaler Devices Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 05: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Figure 06: U.S. Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 07: Canada Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 08: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 09: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 10: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 11: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Manually Operated Inhaler Devices, 2012–2027

Figure 12: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Digitally Operated Inhaler Devices, 2012–2027

Figure 13: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 14: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 15: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 16: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 17: North America Respiratory Inhaler Devices Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 18: North America Respiratory Inhaler Devices Market Attractiveness Analysis By Technology, 2017–2027 

Figure 19: North America Respiratory Inhaler Devices Market Attractiveness Analysis By Disease Indication, 2017–2027 

Figure 20: North America Respiratory Inhaler Devices Market Attractiveness Analysis By Country, 2017–2027 

Figure 21: Latin America Respiratory Inhaler Devices Market Value Share By Product (2017)

Figure 22: Latin America Respiratory Inhaler Devices Market Value Share By Technology (2017)

Figure 23: Latin America Respiratory Inhaler Devices Market Value Share By Country (2017)

Figure 24: Latin America Respiratory Inhaler Devices Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 25: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Figure 26: Argentina Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 27: Mexico Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 28: Brazil Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 29: Rest of Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 30: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 31: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 32: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 33: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Manually Operated Inhaler Devices, 2012–2027

Figure 34: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Digitally Operated Inhaler Devices, 2012–2027

Figure 35: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 36: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 37: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 38: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 39: Latin America Respiratory Inhaler Devices Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 40: Latin America Respiratory Inhaler Devices Market Attractiveness Analysis By Technology, 2017–2027 

Figure 41: Latin America Respiratory Inhaler Devices Market Attractiveness Analysis By Disease Indication, 2017–2027 

Figure 42: Latin America Respiratory Inhaler Devices Market Attractiveness Analysis By Country, 2017–2027 

Figure 43: Western Europe Respiratory Inhaler Devices Market Value Share By Product (2017)

Figure 44: Western Europe Respiratory Inhaler Devices Market Value Share By Technology (2017)

Figure 45: Western Europe Respiratory Inhaler Devices Market Value Share By Country (2017)

Figure 46: Western Europe Respiratory Inhaler Devices Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 47: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Figure 48: Germany Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 49: France Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 50: U.K Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 51: Italy Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 52: Spain Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 53: BENELUX Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 54: NORDIC Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 55: Rest of Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 56: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 57: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 58: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 59: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Manually Operated Inhaler Devices, 2012–2027

Figure 60: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Digitally Operated Inhaler Devices, 2012–2027

Figure 61: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 62: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 63: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 64: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 65: Western Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 66: Western Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Technology, 2017–2027 

Figure 67: Western Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Disease Indication, 2017–2027 

Figure 68: Western Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Country, 2017–2027 

Figure 69: Eastern Europe Respiratory Inhaler Devices Market Value Share By Product (2017)

Figure 70: Eastern Europe Respiratory Inhaler Devices Market Value Share By Technology (2017)

Figure 71: Eastern Europe Respiratory Inhaler Devices Market Value Share By Country (2017)

Figure 72: Eastern Europe Respiratory Inhaler Devices Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 73: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Figure 74: Russia Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 75: Rest of Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 76: Poland Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 77: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 78: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 79: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 80: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Manually Operated Inhaler Devices, 2012–2027

Figure 81: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Digitally Operated Inhaler Devices, 2012–2027

Figure 82: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 83: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 84: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 85: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 86: Eastern Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 87: Eastern Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Technology, 2017–2027 

Figure 88: Eastern Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Disease Indication, 2017–2027 

Figure 89: Eastern Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Country, 2017–2027 

Figure 90: APEJ Respiratory Inhaler Devices Market Value Share By Product (2017)

Figure 91: APEJ Respiratory Inhaler Devices Market Value Share By Technology (2017)

Figure 92: APEJ Respiratory Inhaler Devices Market Value Share By Country (2017)

Figure 93: APEJ Respiratory Inhaler Devices Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 94: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Figure 95: China Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 96: Australia & New Zealand Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 97: India Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 98: ASEAN Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 99: Rest of APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 100: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 101: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 102: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 103: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Manually Operated Inhaler Devices, 2012–2027

Figure 104: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Digitally Operated Inhaler Devices, 2012–2027

Figure 105: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 106: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 107: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 108: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 109: APEJ Respiratory Inhaler Devices Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 110: APEJ Respiratory Inhaler Devices Market Attractiveness Analysis By Technology, 2017–2027 

Figure 111: APEJ Respiratory Inhaler Devices Market Attractiveness Analysis By Disease Indication, 2017–2027 

Figure 112: APEJ Respiratory Inhaler Devices Market Attractiveness Analysis By Country, 2017–2027 

Figure 113: Japan Respiratory Inhaler Devices Market Value Share By Product (2017)

Figure 114: Japan Respiratory Inhaler Devices Market Value Share By Technology (2017)

Figure 115: Japan Respiratory Inhaler Devices Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 116: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Figure 117: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 118: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 119: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 120: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Manually Operated Inhaler Devices, 2012–2027

Figure 121: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Digitally Operated Inhaler Devices, 2012–2027

Figure 122: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 123: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 124: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 125: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 126: Japan Respiratory Inhaler Devices Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 127: Japan Respiratory Inhaler Devices Market Attractiveness Analysis By Technology, 2017–2027 

Figure 128: Japan Respiratory Inhaler Devices Market Attractiveness Analysis By Disease Indication, 2017–2027 

Figure 129: MEA Respiratory Inhaler Devices Market Value Share By Product (2017)

Figure 130: MEA Respiratory Inhaler Devices Market Value Share By Technology (2017)

Figure 131: MEA Respiratory Inhaler Devices Market Value Share By Country (2017)

Figure 132: MEA Respiratory Inhaler Devices Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 133: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Figure 134: GCC Countries Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 135: North Africa Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 136: South Africa Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 137: Rest of MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 138: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 139: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 140: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 141: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Manually Operated Inhaler Devices, 2012–2027

Figure 142: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Digitally Operated Inhaler Devices, 2012–2027

Figure 143: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 144: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 145: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 146: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 147: MEA Respiratory Inhaler Devices Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 148: MEA Respiratory Inhaler Devices Market Attractiveness Analysis By Technology, 2017–2027 

Figure 149: MEA Respiratory Inhaler Devices Market Attractiveness Analysis By Disease Indication, 2017–2027 

Figure 150: MEA Respiratory Inhaler Devices Market Attractiveness Analysis By Country, 2017–2027 

Figure 151: Global Respiratory Inhaler Devices Market Attractiveness Analysis by Region, 2017–2027 

Figure 152: Global Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 153: Global Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 154: Global Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 155: Global Respiratory Inhaler Devices Market Attractiveness Analysis by Product Type, 2017–2027 

Figure 156: Global Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 157: Rest of Global Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 158: Global Respiratory Inhaler Devices Market Attractiveness Analysis by Technology, 2017–2027 

Figure 159: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 160: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 161: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 162: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 163: Global Respiratory Inhaler Devices Market Attractiveness Analysis by Disease Indication, 2017–2027 

Figure 164: Global Respiratory Inhaler Devices Market Value Analysis and Forecast, 2016–2027 (US$ Mn)

Figure 165: Global Respiratory Inhaler Devices Market Absolute $ Opportunity (US$ Mn), 2016–2027

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology